Actavis Pharmaceutical is a global pharmaceutical company involved in the development, manufacture, and distribution of its own brand-named pharmaceuticals as well as the manufacture and distribution of generic pharmaceutical products. The company particularly offers a number of generic products from a company it had acquired, Watson Pharmaceuticals. It markets a number of prescription and over-the-counter medications. The trusted pharmaceutical company’s global headquarters is in Dublin, Ireland, and its headquarters in the United States is in New Jersey.
Actavis Pharmaceutical changed its name to Allergan PLC in 2015 to continue its brand products but announced that its generic products would continue under the Actavis label. It is still known as Actavis, Inc. in Europe and Canada. Later in August 2016, Actavis Generics was acquired by leading pharmaceutical, Teva Pharmaceutical Company.
The company manufactures hundreds of different medicinal solutions. Actavis Pharmaceutical was also known for its generic formulations of medications as well as their own brand of medications. Its brand name medicines are still marketed by Allergan and the generic solutions. It has been transferred to Teva Pharmaceuticals.
Some of the notable products of the company are such as Actonel, which is used to treat the complications of osteoporosis, Androderm patch, which is a transdermal patch used to treat issues with low testosterone levels as a result of surgery, disease, or some other disorder. Some generic antidepressant medicines like selective serotonin reuptake inhibitors and tricyclic antidepressants also manufactured by the company.
There are no products to list.